
TC BioPharm signs LoI to acquire ophthalmic pharma company
TC BioPharm (TCBP) has signed a non-binding letter of intent (LoI) to acquire an ophthalmic pharmaceutical company focused on commercialising intraocular pressure-minimising therapies for individuals with glaucoma and ocular hypertension. The target …